Filter
8456
Filtered Results: 8456
Text search:
medicines
use
Featured
Recommendations
771
New Publications
2065
Language
Document type
No document type
4543
Studies & Reports
1501
Guidelines
1160
Manuals
443
Strategic & Response Plan
259
Fact sheets
200
Training Material
160
Situation Updates
75
Resource Platforms
34
Brochures
28
Infographics
24
Online Courses
16
Videos
11
App
2
Countries / Regions
India
385
Global
315
Kenya
229
South Africa
197
Ethiopia
165
Uganda
152
Sierra Leone
151
Nepal
147
Western and Central Europe
145
Africa
144
Nigeria
143
Latin America and the Carribbean
138
Liberia
136
Malawi
118
Bangladesh
114
Tanzania
113
Myanmar / Burma
103
Zambia
102
Ukraine
98
Ghana
95
Syria
92
Rwanda
86
Brazil
80
Congo, Democratic Republic of
76
Philippines
66
Eastern Europe
63
Mozambique
60
Russia
60
Namibia
58
Zimbabwe
56
South–East Asia Region
54
Guinea
45
Senegal
45
Venezuela
44
Burkina Faso
43
Asia
43
Germany
41
East and Southern Africa
41
West and Central Africa
41
Lesotho
40
Cambodia
38
Indonesia
38
Middle East and North Africa
38
South Sudan
36
Cameroon
35
Haiti
35
Yemen
32
Paraguay
30
Colombia
29
Botswana
27
Eastern Europe and Central Asia
26
Peru
24
Eswatini/ Swaziland
22
Benin
21
Mali
20
USA
19
Sudan
19
Ecuador
18
Bolivia
18
Pakistan
17
Afghanistan
17
Lebanon
17
Madagascar
17
Chile
17
Thailand
16
Angola
16
Vietnam
16
Côte d’Ivoire / Ivory Coast
14
Jordan
13
China
13
Western Pacific Region
13
Moldova
13
Argentina
12
Sri Lanka
12
Niger
11
Somalia
11
Central African Republic
11
Tajikistan
11
Spain
11
Iraq
10
Georgia
10
North America
10
Chad
9
Mexico
9
Albania
9
Southern Africa
9
North Macedonia
8
Laos
8
United Kingdom
8
El Salvador
7
Libya
7
Palestine
7
Kyrgyzstan
7
Portugal
7
Guinea-Bissau
6
Turkey
6
Egypt
6
Iran
6
Kazakhstan
6
Saudi Arabia
5
Papua New Guinea
5
Guatemala
5
Poland
5
Jamaica
5
Belarus
5
Morocco
4
Hungary
4
Burundi
4
Nicaragua
4
Bhutan
4
Canada
4
Estonia
4
Romania
4
Gambia
3
Malaysia
3
Serbia
3
Honduras
3
Greece
3
Fiji
3
Armenia
3
Timor Leste/ East Timor
3
Qatar
3
Uruguay
3
Japan
3
France
3
Mauritius
3
Tunisia
3
Togo
2
Mauritania
2
Other region
2
Italy
2
Mongolia
2
Congo-Brazzaville
2
Bulgaria
2
Lithuania
2
Uzbekistan
2
Australia
2
Gabon
2
Turkmenistan
2
South Korea
2
Israel
2
Bosnia and Herzegovina
2
Singapore
1
Dominican Republic
1
Switzerland
1
Cuba
1
Solomon Islands
1
Djibouti
1
Slovakia
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3089
Clinical Guidelines
702
Public Health
486
Women & Child Health
384
Key Resources
261
Capacity Building
173
Pharmacy & Technologies
104
Annual Report MEDBOX
3
Toolboxes
COVID-19
794
Mental Health
746
HIV
666
TB
496
AMR
361
Caregiver
259
Disability
253
Pharmacy
244
Planetary Health
239
NCDs
232
Ebola
224
NTDs
213
Conflict
200
Rapid Response
195
Refugee
159
Global Health Education
121
Natural Hazards
81
Health Financing Toolbox
63
Zika
55
Specific Hazards
46
Social Ethics
40
Cholera
30
Polio
22
Health Financing
2
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Countr...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP ...rs who tested HIV positive in randomized controlled trials or open-label studies. However, PrEP-selected HIV drug resistance could potentially negatively impact the effectiveness of treatment options among PrEP users who acquire HIV, since there is a potential for overlapping resistance profiles between antiretroviral drugs used for both PrEP and first-line antiretroviral therapy.
Helping Children Live with HIV offers a holistic approach by building on the existing knowledge of parents and caregivers and respecting the importance of other local resources. It integrates health care, illness prevention, and psychosocial support for children and families coping with poverty, foo...
High quality of care in family planning (FP) services has been found to be associated with increased and continued use of contraceptive methods. The interpersonal skills and technical competence of the provider is one of the main components of quali...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to inves...
Over the reporting period, THP-Burkina Faso (THP-Burkina) maintained a continuous focus on ensuring the selfreliance of the health program in each of its epicenters. Building upon its exclusive use of government-run health clinics at its epicenters,...
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary...
AWaRe – a new WHO tool to help countries improve antibiotic treatment, increase access and reduce resistance. We can reduce or even reverse antibiotic resistance by using antibiotics more responsibly. But how do we do that and still ensure that patients are treated effectively?WHO has developed a ...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern ..., and has the potential to impact overall global development. It is important, therefore, to elevate AMR beyond health as part of a larger development agenda in the context of the Sustainable Development Goals (SDGs). This report provides in-depth technical discussions in areas that have direct implications to the containment of AMR as a development agenda. The report is organized in five chapters which served as the technical background documents for the Biregional Technical Consultation on AMR in Asia, 14-15 April 2016. More information from the meeting is available in the WHO Meeting Report: Biregional Technical Consultation on Antimicrobial Resistance in Asia. The meeting was the first time senior officials from the Ministry of Health and Ministry of Agriculture across Asia came together to tackle AMR
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
The purpose of these guidelines is to give practical advice to doctors so that all services and models of care used by doctors and health workers are encouraged to consider the use of telemedicine a...
April 2020
This document explains the scope of the logistics services provided by the National Logistics Cluster, in support of the COVID-19 response in Nepal, how humanitarian actors and Nepal Government may access these services, and the conditions under which these services will be provided. T...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines<...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be ...d in the context of COVID-19. This includes WHO Priority Medical Devices, specifically: surgical masks, non-surgical masks, gloves, googles, face shields, gowns and N95 masks. It is intended for procurement agencies, occupational health departments, infection prevention and control departments or focal points, health facility administrators, biomedical and materials engineering, PPE manufacturers and public health authorities at both national and facility levels.
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of ..., the manual is available in a compiled form and in several separate modules that can be consulted individually. For each module, specific training material is also available to facilitate implementation.
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate ...
COVID 19 Vaccine Perceptions: A 15 country study
recommended
Initial public health responses to control the pandemic focused on promoting protective behaviors among the general population, including frequent hand washing, physical distancing and the use of face masks in public spaces However, many saw these o...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
This publication summarizes the facilitators and barriers that will be encountered in the deinstitutionalization process and identifies useful and proven interventions in Latin American and Caribbean countries. Four areas of work are identified with...
Modelling the health impacts of disruptions to essential health services during COVID-19 Module 1
Several epidemiological models have been created to assess the potential impact of disruptions to essential health services caused by COVID-19 on morbidity and mortality from conditions other than COVI...
